Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Complete Summary

GUIDELINE TITLE

Care of the patient with myopia.

BIBLIOGRAPHIC SOURCE(S)

  • American Optometric Association. Care of the patient with myopia. St. Louis (MO): American Optometric Association; 1997. 75 p. (Optometric clinical practice guideline; no. 15). [231 references]

GUIDELINE STATUS

This is the current release of the guideline.

According to the guideline developer, this guideline has been reviewed on a biannual basis and is considered to be current. This review process involves updated literature searches of electronic databases and expert panel review of new evidence that has emerged since the original publication date.

COMPLETE SUMMARY CONTENT

 
SCOPE
 METHODOLOGY - including Rating Scheme and Cost Analysis
 RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS
 QUALIFYING STATEMENTS
 IMPLEMENTATION OF THE GUIDELINE
 INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

SCOPE

DISEASE/CONDITION(S)

Myopia:

  • Simple myopia
  • Nocturnal myopia
  • Pseudomyopia
  • Degenerative myopia
  • Induced myopia

GUIDELINE CATEGORY

Diagnosis
Evaluation
Management

CLINICAL SPECIALTY

Optometry

INTENDED USERS

Health Plans
Optometrists

GUIDELINE OBJECTIVE(S)

  • To accurately diagnose the different types of myopia
  • To improve the quality of care rendered to patients with myopia
  • To inform and educate parents, patients, and other health care practitioners about the options of correction, control, or reduction of myopia
  • To decrease visual morbidity related to high degrees of myopia

TARGET POPULATION

Patients of all ages with myopia

INTERVENTIONS AND PRACTICES CONSIDERED

Diagnosis of Myopia

  1. Patient History
    • Simple Myopia
    • Nocturnal Myopia
    • Pseudomyopia
    • Degenerative Myopia
    • Induced Myopia
  2. Ocular Examination
    • Visual Acuity
    • Refraction
    • Ocular Motility, Binocular Vision, and Accommodation
    • Ocular Health Assessment and Systemic Health Screening
  3. Supplemental Testing

Treatment

  1. Optical Correction
  2. Medical (Pharmaceutical)
  3. Vision Therapy
  4. Orthokeratology
  5. Refractive Surgery

MAJOR OUTCOMES CONSIDERED

Not stated

METHODOLOGY

METHODS USED TO COLLECT/SELECT EVIDENCE

Hand-searches of Published Literature (Primary Sources)
Searches of Electronic Databases

DESCRIPTION OF METHODS USED TO COLLECT/SELECT THE EVIDENCE

The guideline developer performed literature searches using the National Library of Medicine's Medline database and the VisionNet database.

NUMBER OF SOURCE DOCUMENTS

Not stated

METHODS USED TO ASSESS THE QUALITY AND STRENGTH OF THE EVIDENCE

Expert Consensus (Committee)

RATING SCHEME FOR THE STRENGTH OF THE EVIDENCE

Not applicable

METHODS USED TO ANALYZE THE EVIDENCE

Review

DESCRIPTION OF THE METHODS USED TO ANALYZE THE EVIDENCE

Not applicable

METHODS USED TO FORMULATE THE RECOMMENDATIONS

Not stated

RATING SCHEME FOR THE STRENGTH OF THE RECOMMENDATIONS

Not applicable

COST ANALYSIS

A formal cost analysis was not performed and published cost analyses were not reviewed.

METHOD OF GUIDELINE VALIDATION

Internal Peer Review

DESCRIPTION OF METHOD OF GUIDELINE VALIDATION

The Reference Guide for Clinicians was reviewed by the American Optometric Association (AOA) Clinical Guidelines Coordinating Committee and approved by the AOA Board of Trustees.

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The major symptom of myopia (blurred distance vision) and the major sign (reduced unaided distance visual acuity) can generally be improved with appropriate minus power lenses.

The examination of patients who have any of the forms of myopia should include a comprehensive patient history, measurement of refraction, investigation of accommodation and vergence function, and evaluation of ocular health. The patient should be advised about available treatment options and counseled regarding the need for follow-up care.

The frequency and composition of evaluation and management visits for myopia are summarized in the table, below.

Frequency and Composition of Evaluation and Management Visits for Myopia


Type of Patient Number of Evaluation Visits Treatment Options Frequency of Follow-Up Visits Composition of Follow-Up Evaluations Management Plan
VA REF A/V OH

Simple myopia 1 Myopia correction: optical correction vision therapy Children: annually
Adults: every 2 yr or p.r.n.
Each visit

 

Each visit Each visit Each visit Prescribe refractive correction; provide or refer patient for vision therapy; patient education.
Possible myopia control: optical correction, vision therapy Every 6 mos Each visit Each visit Each visit Contact lenses: anterior segment each visit posterior segment annually
Bifocals: annually
Prescribe refractive correction; provide or refer patient for vision therapy; recommend vision hygiene improvement; patient education
Myopia reduction: orthokeratology, refractive surgery Variable, depending on method of myopia reduction Each visit Each visit Annually Anterior segment: each visit, Posterior segment: annually Provide or refer patient for orthokeratology; refer patient for refractive surgery; patient education.
Nocturnal myopia 1 to 2 Optical correction 3 to 4 wk after dispensing of prescription, then annually Each visit Annually or p.r.n. Annually Annually Prescribe refractive correction for nighttime seeing; patient education.
Pseudo-myopia 1 to 2 Optical correction, pharmaceutical, vision therapy Every 1 to 4 wk until accommodative excess is eliminated, then annually Each visit Each visit Annually or p.r.n. Annually Prescribe refractive correction; reduce accommodative response with vision therapy; prescribe cycloplegic agents to eliminate accommodative spasm; prevent pseudomyopia with plus lenses; patient education
Degenerative Myopia 1 to 2 Optical correction Annually or more frequently, depending on retinal an ocular changes Each visit Annually or p.r.n. Annually or p.r.n. Each visit Prescribe refractive correction; provide or refer for appropriate treatment for retinal complications; patient education
Induced myopia 1 to 2 Variable, depending on inducing agent or condition Variable, depending on inducing agent or condition Each visit Each visit Variable, depending on inducing agent or condition Variable, depending on inducing agent or condition Identify inducing agent; prevent further exposure to causative agent; refer to appropriate practitioner for additional testing and treatment; patient education

.


VA = visual acuity testing
REF = refraction
A/V = accommodative vergence testing
OH = ocular health assessment
p.r.n. = as necessary

CLINICAL ALGORITHM(S)

An algorithm is provided for Optometric Management of the Patient with Myopia.

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is not specifically stated for each recommendation.

BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS

POTENTIAL BENEFITS

Accurate optometric diagnosis and improved visual acuity for myopic patients

POTENTIAL HARMS

Not stated

QUALIFYING STATEMENTS

QUALIFYING STATEMENTS

Clinicians should not rely on this Clinical Guideline alone for patient care and management. Please refer to the references and other sources listed in the original guideline for a more detailed analysis and discussion of research and patient care information.

IMPLEMENTATION OF THE GUIDELINE

DESCRIPTION OF IMPLEMENTATION STRATEGY

An implementation strategy was not provided.

IMPLEMENTATION TOOLS

Clinical Algorithm
Patient Resources

For information about availability, see the "Availability of Companion Documents" and "Patient Resources" fields below.

INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES

IOM CARE NEED

Getting Better

IOM DOMAIN

Effectiveness
Patient-centeredness

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • American Optometric Association. Care of the patient with myopia. St. Louis (MO): American Optometric Association; 1997. 75 p. (Optometric clinical practice guideline; no. 15). [231 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1997 (reviewed 2006)

GUIDELINE DEVELOPER(S)

American Optometric Association - Professional Association

SOURCE(S) OF FUNDING

Funding was provided by the Vision Service Plan (Rancho Cordova, California) and its subsidiary Altair Eyewear (Rancho Cordova, California)

GUIDELINE COMMITTEE

American Optometric Association Consensus Panel on Care of the Patient with Myopia

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Members: David A. Goss, O.D., Ph.D. (Principal Author); Theodore P. Grosvenor, O.D., Ph.D.; Jeffrey T. Keller, O.D., M.P.H.; Wendy Marsh-Tootle, O.D., M.S.; Thomas T. Norton, Ph.D.; Karla Zadnik, O.D., Ph.D.

AOA Clinical Guidelines Coordinating Committee Members: John F. Amos, O.D., M.S. (Chair); Kerry L. Beebe, O.D.; Jerry Cavallerano, O.D., Ph.D.; John Lahr, O.D.; Richard L. Wallingford, Jr., O.D.

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

According to the guideline developer, this guideline has been reviewed on a biannual basis and is considered to be current. This review process involves updated literature searches of electronic databases and expert panel review of new evidence that has emerged since the original publication date.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American Optometric Association Web site.

Print copies: Available from the American Optometric Association, 243 N. Lindbergh Blvd., St. Louis, MO 63141-7881

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

The following is available:

  • Answers to your questions about nearsightedness. St. Louis, MO: American Optometric Association. (Patient information pamphet).

Print copies: Available from the American Optometric Association, 243 N. Lindbergh Blvd., St. Louis, MO 63141-7881; Web site, www.aoanet.org.

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This summary was completed by ECRI on December 1, 1999. The information was verified by the guideline developer on January 31, 2000.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo